Chronic urticaria (CU) is a dermatological condition characterized by recurrent wheals (hives), angioedema (deep tissue swelling), or both, persisting for over 6 weeks. 1 Unlike acute urticaria, which ...

Overall, the CUPID-C trial corroborates earlier evidence that dupilumab can meaningfully reduce itch and hives in ...

A prominent feature of CSU is its association with angioedema, observed in approximately 40% to 50% of patients with CSU; around 10% of patients primarily experience angioedema as the main symptom.

Patient also had seemingly unexplained concomitant mild anemia, leukocytosis, and eosinoph ...

Medically reviewed by Casey Gallagher, MD CSU is a skin condition that causes hives and swelling lasting six weeks or more.The cause of the condition is often unknown, but in the majority of cases ...

Barzolvolimab improved symptoms in chronic spontaneous urticaria, supporting mast cell targeting as a novel treatment strategy. Read more.

Sustained off-treatment efficacy despite barzolvolimab clearance and normalization of tryptase, suggesting disease modification in patients ...

With barzolvolimab re-treatment, 62% of patients with ColdU and 60% of patients with SD had a complete response at Week 20 in the OLE. These findings are consistent with the complete response rates in ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window "Medical ...

Please provide your email address to receive an email when new articles are posted on . Barzolvolimab binds receptor tyrosine kinase KIT to inhibit its activity, which mast cells need for survival.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Barzolvolimab is an anti-KIT monoclonal antibody. 75% of ...

Acute urticaria affects individuals of all ages but the average age at presentation is in the early 20s. 1 Reports indicate a female preponderance for acute urticaria, except in young children; in ...